Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine

References

• Thomas CP, Fullerton CA, Montejano, L, et al. Medication-assisted treatment with buprenorphine: assessing the evidence. PS. 2014;65(2):158–170.
   Google Scholar
• Ling W, Charuvastra C, Collins JF, et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction. 1998;93(4):475–486.
   PubMed Web of Science ®Google Scholar
• Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.
   PubMed Web of Science ®Google Scholar
• Eibl JK, Gauthier G, Pellegrini D, et al. The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting. Drug Alcohol Depend. 2017;176:133–138.
   PubMed Web of Science ®Google Scholar
• Zheng W, Nickasch M, Lander L, et al. Treatment outcome comparison between telepsychiatry and face-to-face buprenorphine medication-assisted treatment for opioid use disorder: a 2-year retrospective data analysis. J Addict Med. 2017;11(2):138–144.
   PubMed Web of Science ®Google Scholar
• Hilty D, Yellowlees PM, Parrish MB, Chan S. Telepsychiatry: effective, evidence-based, and at a tipping point in health care delivery? Psychiatr Clin North Am. 2015;38(3):559–592.
   PubMed Web of Science ®Google Scholar
• Rosenblatt RA, Andrilla CH, Catlin M, Larson EH. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med. 2015;13(1):23–26.
   PubMed Web of Science ®Google Scholar
• Molfenter T, Boyle M, Holloway D, Zwick J. Trends in telemedicine use in addiction treatment. Addict Sci Clin Pract. 2015;10:14.
   PubMed Web of Science ®Google Scholar
• Weintraub E, Greenblatt AD, Chang J, Himelhoch S, Welsh C. Expanding access to buprenorphine treatment in rural areas with the use of telemedicine. Am J Addict. 2018;27(8):612–617.
   PubMed Web of Science ®Google Scholar
• Molfenter T, Brown R, O’Neill A, Kopetsky E, Toy A. Use of telemedicine in addiction treatment: current practices and organizational implementation characteristics. Int J Telemed Appl. 2018;2018:3932643.
   PubMed Web of Science ®Google Scholar
• Scott Kruse C, Karem P, Shifflett K, Vegi L, Ravi K, Brooks M. Evaluating barriers to adopting telemedicine worldwide: a systematic review. J Telemed Telecare. 2018;24(1):4–12.
   PubMed Web of Science ®Google Scholar
• Andrilla CHA, Coulthard C, Larson EH. Barriers rural physicians face prescribing buprenorphine for opioid use disorder. Ann Fam Med. 2017;15(4):359–362.
   PubMed Web of Science ®Google Scholar
• Grubaugh AL, Cain GD, Elhai JD, Patrick SL, Frueh BC. Attitudes toward medical and mental health care delivered via telehealth applications among rural and urban primary care patients. J Nerv Ment Dis. 2008;196(2):166–170.
   PubMed Web of Science ®Google Scholar
• DeFlavio JR, Rolin SA, Nordstrom BR, Kazal LA Jr. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians. Rural Remote Health. 2015;15:3019.
   PubMed Web of Science ®Google Scholar
• Office USGA. VA Health Care: actions needed to improve oversight of community-based outpatient clinics. 2019. https://www.gao.gov//assets/700/691221.pdf. Accessed GAO-18-375.
   Google Scholar
• Wyse JJ, Gordon AJ, Dobscha SK, et al. Medications for opioid use disorder in the Department of Veterans Affairs (VA) Health Care System: historical perspective, lessons learned, and next steps. Subst Abus. 2018;39(2):139–144.
   PubMed Web of Science ®Google Scholar
• Management OoP. VA plans, budget, and performance. 2019. https://www.va.gov/performance/.
   Google Scholar
• Affairs OoPaI. VA expands telehealth by allowing health care providers to treat patients across state lines. 2016. https://www.va.gov/opa/pressrel/pressrelease.cfm?id=4054.
   Google Scholar
• ATLAS.ti. The qualitative data analysis and research software. 2019. https://atlasti.com/.
   Google Scholar
• Strauss AL. Qualitative Analysis for Social Scientists. Cambridge: University of Cambridge Press; 1987.
   Google Scholar
• Glaser BG, Strauss AL. The Discovery of Grounded Theory: Strategies for Qualitative Research. Oxon. London: Routledge; 2017.
   Google Scholar
• Drug Enforcement Administration DoJ. Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Interim final rule with request for comments. Fed Regist. 2009;74(64):15595–15625.
   PubMedGoogle Scholar
• Lee JD, Grossman E, DiRocco D, Gourevitch MN. Home buprenorphine/naloxone induction in primary care. J Gen Intern Med. 2009;24(2):226–232.
   PubMed Web of Science ®Google Scholar
• Damschroder LJ, Hagedorn HJ. A guiding framework and approach for implementation research in substance use disorders treatment. Psychol Addict Behav. 2011;25(2):194–205.
   PubMed Web of Science ®Google Scholar
• McQueen L, Mittman BS, Demakis JG. Overview of the Veterans Health Administration (VHA) Quality Enhancement Research Initiative (QUERI). J Am Med Inform Assoc. 2004;11(5):339–343.
   PubMed Web of Science ®Google Scholar
• Stetler CB, Mittman BS, Francis J. Overview of the VA Quality Enhancement Research Initiative (QUERI) and QUERI theme articles: QUERI Series. Implement Sci. 2008;3:8.
   PubMed Web of Science ®Google Scholar
• Huskamp HA, Busch AB, Souza J, et al. How is telemedicine being used in opioid and other substance use disorder treatment? Health Affairs. 2018;37(12):1940–1947.
   PubMed Web of Science ®Google Scholar
• Lin LA, Bohnert ASB, Kerns RD, Clay MA, Ganoczy D, Ilgen MA. Impact of the opioid safety initiative on opioid-related prescribing in veterans. Pain. 2017;158(5):833–839.
   PubMed Web of Science ®Google Scholar
• US Department of Veterans Affairs. Improving the safety of opioid treatment. 2019. https://www.hsrd.research.va.gov/news/feature/opioid_safety.cfm.
   Google Scholar
• Komaromy M, Bartlett J, Manis K, Arora S. Enhanced primary care treatment of behavioral disorders with echo case-based learning. PS. 2017;68(9):873–875.
   Google Scholar
• LaBelle CT, Han SC, Bergeron A, Samet JH. Office-based opioid treatment with buprenorphine (OBOT-B): statewide implementation of the Massachusetts Collaborative Care Model in community health centers. J Subst Abuse Treat. 2016;60:6–13.
   PubMed Web of Science ®Google Scholar
• Manhapra A, Petrakis I, Rosenheck R. Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration. Am J Addict. 2017;26(6):572–580.
   PubMed Web of Science ®Google Scholar
• Lin L, Casteel D, Shigekawa E, Weyrich MS, Roby DH, McMenamin SB. Telemedicine-delivered treatment interventions for substance use disorders: a systematic review. J Subst Abuse Treat. 2019;101:38–49.
   PubMed Web of Science ®Google Scholar
• Slightam CGA, Hu J, Jacobs JC, Gurmessa T, Zulman DM. Patient preference for virtual care: results from a national survey of Veterans. 2019 HSR&D/QUERI National Conference Abstract – Poster #4037; 2019; Washington, DC.
   Google Scholar
• Lund BM. Distributed care versus centralized specialty service models for medication assisted treatment with buprenorphine. HSR&D/QUERI National Conference Abstract - Poster #4130; 2019; Washington, DC.
   Google Scholar
• Sayre GGZ, Heyworth L, Carey EP, Young JP, Hogan T. Bringing veteran care closer to home: priorities, partnerships, and engaged research and evaluation of virtual patient-facing technologies. 2019 HSR&D/QUERI National Conference Abstract – Poster#2005; 2019; Washington, DC.
   Google Scholar
• Department of Veterans Affairs (VA). A primer on telehealth. 2019. https://crsreports.congress.gov/product/pdf/R/R45834.
   Google Scholar